5 EASY FACTS ABOUT IS ABBV-744 EFFECTIVE FOR HEMATOLOGIC CANCERS? DESCRIBED

In Section A, participants will obtain distinct doses and schedules of oral ABBV-744 tablet to detect Harmless dosing routine. Further participants will be enrolled within the recognized monotherapy dosign program. In Section B, contributors will get oral ruxolitinib and ABBV-744 will likely be offered as "increase-on" therapy. In Section C, contri